Kaleido BiosciencesKLDO
13F holders, Q1 2025 (March 31)2holders
2new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Kaleido Biosciences Inc. (KLDO) in their 13F filings, unchanged from Q3 2024. 2 opened new positions and 0 sold out. The largest holders were Bay Harbor Wealth Management, LLC ($2) and Hantz Financial Services, Inc. ($0).
- Company
- Kaleido Biosciences Inc.
- CUSIP
- 483347100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q1 2025: 2,650 shares bought, net +2,650 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Bay Harbor Wealth Management, LLC | 0.00% | New | 2,300 | $2 |
| Hantz Financial Services, Inc. | 0.00% | New | 350 | $0 |
"% of holder's portfolio" is KLDO's weight in each manager's 13F, not the share of Kaleido Biosciences Inc. the manager owns.